Send to friend Linked
Adnexus Therapeutics
|
| Website | http://www.adnexustx.com/ |
|---|---|
| Location | Boston |
| Industry | Healthcare & Pharmaceuticals |
| Revenue | unknown |
| Investment | unknown |
| Growth | unknown |
| Employees | unknown |
Adnexus discovers and develops a novel, proprietary class of targeted biologics called Adnectinsô. We believe Adnectins possess competitive therapeutic, manufacturing and commercial advantages over traditional targeted therapeutic classes, such as antibodies and small molecules.
-
News: Awarepoint Corporation Closes $13.3 M Series D Financing Round
-
News: Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
-
News: Noubar Afeyan Receives 2008 Ellis Island Medal of Honor
-
News: AppNexus Secures $8 Million in Series B Funding
-
News: Drug research faces long odds
-
News: Research and Markets: Evolving Trends in Licensing: Examine Expert Strategies for Building and Retaining Value in ...
-
News: IPO? In This Market?
-
News: Venrock Inducted Into the Private Equity Hall of Fame
-
New Job: Scientist/Sr. Scientist - Protein Design
-
New Job: Director, Protein Analytics
